In a phase 2 study, SAR402663 gene therapy for wet age-related macular degeneration showed positive efficacy and safety ...

Investigaciones realizadas en distintos países analizaron la exposición prolongada a partículas contaminantes y su posible ...

In this video from the American Academy of Ophthalmology meeting, Dilraj Grewal, MD, highlights phase 2 and phase 3 data in age-related macular degeneration.

Galardonan “Cuando el iris crea nuevos caminos: glaucoma neovascular” en concurso de Fotografía Morfológica   Estudiantes de ...

Estudiantes de la Licenciatura en Médico Cirujano de la Universidad Anáhuac Puebla fueron reconocidos entre los tres mejores ...

A one-year study from Northwest China reports that ultrasound cycloplasty reduced intraocular pressure by nearly 60 percent, halved dangerous 24-hour pressure fluctuations, and produced no severe ...

Optometrists today have more tools than ever at their disposal to help detect, treat and manage disease. To help you keep up with the constant innovation, check out the other articles featured in the ...

Experimental Cataract Lens Can Treat Glaucoma Through Time-Release Drugs By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 13, 2026 (HealthDay News) — An experimental cataract lens also can help ...

Share on Pinterest A common cholesterol-lowering drug may also help lower glaucoma risk. Trevor Williams/ Getty Images About 95 million people around the world are living with glaucoma. There is ...

The connection between systemic blood pressure (BP) and glaucoma remains unclear. There is a suggestion that calcium channel blockers, one of the treatments for high BP, may cause glaucoma. Optic ...

In a phase 2a clinical trial, investigators evaluated the safety of intravitreal VIS-101 in patients with neovascular AMD. Patients with nAMD can achieve solid visual and structural gains, and be ...